Xenoestrogens regulate the activity of arginine methyltransferases.
Arginine methylation is a common post-translational modification that has been strongly implicated in transcriptional regulation. The arginine methyltransferases (PRMTs) were first reported as transcriptional coactivators for the estrogen and androgen receptors. Compounds that inhibit these enzymes will provide us with valuable tools for dissecting the roles of these enzymes in cells, and will possibly also have therapeutic applications. In order to identify such inhibitors of the PRMTs, we have previously performed a high-throughput screen using a small molecule library. These compounds were named arginine methyltransferase inhibitors (AMIs). The majority of these inhibitors were polyphenols, and one in particular (AMI-18) shared additional features with a group of known xenoestrogens. We, thus, tested a panel of xenoestrogens and found that a number of them possess the ability to inhibit PRMT activity, in vitro. These inhibitors primarily target CARM1, and include licochalcone A, kepone, benzyl 4-hydroxybenzoate, and tamoxifen. We developed a cell-based reporter system for CARM1 activity, and showed that tamoxifen (IC(50) =30 μM) inhibits this PRMT. The ability of these compounds to regulate the activity of transcriptional coactivators may be an unappreciated mechanism of action for xenoestrogens, and might also explain the efficacy of high-dose tamoxifen treatment on estrogen receptor negative cancers.
Department of Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, TX 78957, USA.
Donghang
D
Cheng
Mark T
MT
Bedford
D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D004967:Estrogens / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D008780:Methyltransferases / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism*; D015394:Molecular Structure; D011484:Protein-Arginine N-Methyltransferases; D054852:Small Molecule Libraries; D015262:Xenobiotics / Q000737:chemistry / Q000494:pharmacology*
D004791:Enzyme Inhibitors; D004967:Estrogens; D047908:Intracellular Signaling Peptides and Proteins; D054852:Small Molecule Libraries; D015262:Xenobiotics; D008780:Methyltransferases; C077013:PRMT2 protein, human; D011484:Protein-Arginine N-Methyltransferases
Mol Cell Biol. 2000 Dec;20(24):9423-33
11094092
Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10602-7
9724750
J Biol Chem. 2001 Jul 6;276(27):25309-17
11316813
J Med Chem. 2007 May 17;50(10):2319-25
17432842
J Med Chem. 2010 Aug 26;53(16):6028-39
20666457
J Biol Chem. 2010 Jan 8;285(2):1147-52
19897492
Endocr Rev. 2004 Feb;25(1):45-71
14769827
Regul Toxicol Pharmacol. 2002 Aug;36(1):118-30
12383724
ChemMedChem. 2010 Mar 1;5(3):398-414
20091730
ACS Chem Biol. 2010 Nov 19;5(11):1053-63
20701328
Cancer. 2004 Jul 1;101(1):83-9
15221992
Bioorg Med Chem Lett. 2009 Dec 1;19(23):6725-32
19836951
Cancer Res. 1999 Jul 1;59(13):3090-9
10397250
Cancer Res. 2008 Jan 1;68(1):301-6
18172323
Anal Bioanal Chem. 2004 Feb;378(3):582-7
14564443
Science. 1999 Jun 25;284(5423):2174-7
10381882
Mol Cell. 2007 Jan 12;25(1):71-83
17218272
J Med Chem. 2008 Apr 10;51(7):2279-90
18348515
Am J Cardiol. 2002 Jul 3;90(1A):35F-43F
12106639
ChemMedChem. 2007 Jul;2(7):987-91
17458842
Curr Med Chem. 2005;12(4):481-99
15720256
J Biol Chem. 2002 Feb 1;277(5):3537-43
11724789
Cancer Res. 1985 Jun;45(6):2462-5
3157445
Curr Clin Pharmacol. 2010 Feb;5(1):1-29
19891604
Bioorg Med Chem Lett. 2009 Feb 15;19(4):1218-23
19131248
Cancer Res. 2009 Nov 1;69(21):8217-22
19843848
J Am Chem Soc. 2008 Apr 9;130(14):4574-5
18338885
Chembiochem. 2010 Jun 14;11(9):1219-23
20480486
Proc Natl Acad Sci U S A. 2006 Sep 5;103(36):13351-6
16938873
Anticancer Drugs. 1998 Aug;9(7):581-6
9773800
Mol Cell. 2009 Jan 16;33(1):1-13
19150423
J Cell Biochem. 2004 Feb 15;91(3):491-503
14755680
Semin Oncol. 1997 Feb;24(1 Suppl 1):S1-65-S1-70
9045318
J Biol Chem. 2010 Mar 5;285(10):7143-52
20022955
Prostate. 2006 Sep 1;66(12):1292-301
16705743
Assay Drug Dev Technol. 2003 Dec;1(6):835-42
15090229
Mol Biosyst. 2011 Jan;7(1):48-51
20607165
Neurology. 2006 Jul 11;67(1):20-7
16832072
J Biol Chem. 2004 Jun 4;279(23):23892-9
15056663
J Biol Chem. 2002 Jul 19;277(29):26031-5
11983685
EMBO Rep. 2002 Mar;3(3):268-73
11850402
Bioorg Med Chem. 2006 May 15;14(10):3491-5
16434201
Nucleic Acids Res. 2010 Apr;38(7):2201-16
20047962
Mol Cell Biol. 2006 Nov;26(21):7846-57
16923966
J Biol Chem. 2000 Nov 17;275(46):35986-93
10964929
Urology. 2001 Apr;57(4):650-4
11306370
Biochem J. 2005 Feb 15;386(Pt 1):85-91
15473865
Bioorg Med Chem Lett. 2008 Aug 1;18(15):4438-41
18619839
Expert Opin Investig Drugs. 2004 Nov;13(11):1457-68
15500393
Mol Cell Biol. 2007 Jan;27(1):120-34
17043108
Mol Cell. 2001 Dec;8(6):1207-17
11779497
Proc Natl Acad Sci U S A. 2003 May 27;100(11):6464-8
12756295
Mol Cell. 2005 May 13;18(4):413-24
15893725
Science. 2001 Aug 3;293(5531):853-7
11387442
Bioorg Med Chem Lett. 2009 Sep 1;19(17):5063-6
19632837
Bioorg Med Chem Lett. 2007 Aug 1;17(15):4150-3
17570663
FEBS J. 2010 May;277(9):2096-108
20345902
Bioorg Med Chem Lett. 2009 Jun 1;19(11):2924-7
19419866
J Med Chem. 2007 Mar 22;50(6):1241-53
17323938
Neuro Oncol. 2006 Jan;8(1):47-52
16443947